Cargando…
Valuing mortality risk in the time of COVID-19
In evaluating the appropriate response to the COVID-19 pandemic, a key parameter is the rate of substitution between wealth and mortality risk, conventionally summarized as the value per statistical life (VSL). For the United States, VSL is estimated as approximately $10 million, which implies the v...
Autor principal: | Hammitt, James K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656098/ https://www.ncbi.nlm.nih.gov/pubmed/33199940 http://dx.doi.org/10.1007/s11166-020-09338-1 |
Ejemplares similares
-
Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis
por: Robinson, Lisa A., et al.
Publicado: (2019) -
Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime
por: Adler, Matthew D., et al.
Publicado: (2021) -
Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve
por: Hammitt, James K., et al.
Publicado: (2023) -
Premature Deaths, Statistical Lives, and Years of Life Lost: Identification, Quantification, and Valuation of Mortality Risks
por: Hammitt, James K., et al.
Publicado: (2019) -
Socio-Cultural Values Are Risk Factors for COVID-19-Related Mortality
por: Endress, Ansgar D.
Publicado: (2022)